Early Signs of Multiple Sclerosis: What to Watch For
Explore the clinic directoryIn this article
- At a Glance
- Key Takeaways
- Why Early Recognition Matters
- What Are the First Signs of MS?
- The Most Common First Symptoms
- Less Common but Important Early Signs
- Red Flags: When to Push for Evaluation
- What Else Can Cause Early MS-Like Symptoms?
- What to Do If You Notice Early Signs of MS
- How MS Is Diagnosed
- What a Clinically Isolated Syndrome Means
- Who Treats MS After the First Signs?
- Frequently Asked Questions
- Related Reading
- Sources
The most common early signs of multiple sclerosis (MS) are numbness or tingling, blurred or painful vision in one eye (optic neuritis), unusual fatigue, weakness or clumsiness in a limb, balance problems, and an electric shock feeling down the spine when you bend your neck (Lhermitte’s sign). Numbness and tingling is the first symptom in about 30-40% of people with MS and optic neuritis in about 20-25%, according to Kister and colleagues (2013) and Toosy and colleagues in The Lancet Neurology (2014).
What this article covers
At a Glance
- Diagnosis often comes months or years after the first MS symptom, because early signs are easy to dismiss
- Optic neuritis (vision changes in one eye) is the most recognizable early sign
- Numbness or tingling that persists for more than 48 hours without clear cause warrants neurological evaluation
- Lhermitte’s sign (electric shock sensation down the spine when bending the neck) is highly suggestive of MS
- Early diagnosis and treatment are linked to lower long-term disability
Key Takeaways
- Numbness, tingling or “pins and needles” is the most common first symptom of MS, reported first by about 30-40% of patients (Kister et al., International Journal of MS Care, 2013).
- Optic neuritis, with pain on eye movement and dimmed vision in one eye, is the first sign in about 20-25% of people with MS (Toosy et al., The Lancet Neurology, 2014).
- After a single episode of optic neuritis, about 50% of people develop MS within 15 years, according to the Optic Neuritis Treatment Trial follow-up (2008).
- Fatigue affects about 75-95% of people with MS and is the presenting complaint in about 20%, but on its own it is too common to point to MS (Krupp et al., 2010).
- A neurologist diagnoses MS with the McDonald criteria, using MRI of the brain and spinal cord, often with spinal fluid testing for oligoclonal bands (Thompson et al., The Lancet Neurology, 2018).
- Starting high-efficacy disease-modifying therapy within 2 years of onset was linked to less disability 6 to 10 years later in a 2020 cohort study by He and colleagues.
Why Early Recognition Matters
Multiple sclerosis is an autoimmune disease in which the immune system attacks myelin, the insulating coating around nerve fibers in the brain and spinal cord. Demyelination disrupts nerve signal transmission, causing a wide range of neurological symptoms depending on where the damage occurs [1].

The challenge with MS is that early symptoms are often vague, transient, and easy to attribute to stress, fatigue, or aging. Many people experience their first symptom and wait months or years before seeking evaluation. Others see multiple doctors before someone orders the right tests.
This delay matters. Disease-modifying therapies (DMTs) are most effective when started early, before significant neurodegeneration accumulates. A 2020 cohort study in The Lancet Neurology by He and colleagues found that people who started high-efficacy therapy within 2 years of disease onset had less disability 6 to 10 years later than those who started it later [2].
MS is common enough that these signs deserve attention. A nationwide prevalence study by Wallin and colleagues published in Neurology (2019) found that MS is considerably more common in the United States than older estimates suggested [11]. Women are diagnosed much more often than men, and symptoms usually begin between the ages of 20 and 50.
What Are the First Signs of MS?
The first signs of MS are neurological symptoms that last at least 24 hours, usually develop over hours to days, and often fade over weeks. A first attack typically affects one part of the nervous system: one optic nerve, one area of the spinal cord, or the brainstem. The table below summarizes the early signs this guide covers and the test a clinician usually starts with.
| Early sign | What it feels like | How often it comes first | Usual first test |
|---|---|---|---|
| Numbness or tingling | Pins and needles in a limb, one side of the body, or a band around the trunk lasting more than 48 hours | About 30-40% of patients | MRI of the brain and spinal cord |
| Optic neuritis | Pain behind one eye when it moves, blurred or dim vision, faded colors | About 20-25% of patients | Eye exam and MRI of the brain and orbits with contrast |
| Fatigue | Exhaustion out of proportion to activity that rest does not fix | Presenting complaint in about 20% | Blood work to rule out other causes, then MRI if other signs are present |
| Lhermitte’s sign | An electric shock down the spine or into the limbs when bending the neck forward | Seen in 33-40% of patients at some point | MRI of the cervical spine and brain |
| Weakness or clumsiness | A heavy or dragging leg, tripping, trouble with buttons or writing | Common, often noticed sooner than sensory change | Neurological exam and MRI |
| Balance problems | Unsteadiness, vertigo, feeling drunk without drinking | Less common as a first sign | Neurological exam and brain MRI |
Most people with one of these symptoms do not have MS. The pattern that raises concern is a symptom that lasts for days, comes back in episodes, worsens with heat, or appears alongside a second neurological symptom.
The Most Common First Symptoms
Optic Neuritis
Optic neuritis is the presenting symptom of MS in approximately 20-25% of patients. It causes inflammation of the optic nerve, producing [3]:
- Pain behind one eye, especially with eye movement
- Blurred or dimmed vision in the affected eye
- Reduced color perception (colors look washed out, especially red)
- A central scotoma (blind spot in the center of vision)
Symptoms typically develop over hours to days and peak within 1-2 weeks. Most patients recover vision over 4-6 weeks, though subtle deficits may persist. An isolated episode of optic neuritis carries a 50% risk of developing MS within 15 years, with risk increasing if brain MRI shows other lesions [4].
If you experience sudden vision loss in one eye with pain on eye movement, see an ophthalmologist or neurologist promptly. An MRI of the brain and orbits with contrast is the key diagnostic step.
Sensory Symptoms: Numbness and Tingling
Numbness, tingling (paresthesias), or a “pins and needles” sensation is the most common early MS symptom overall, reported as the first symptom in 30-40% of patients. These sensory changes reflect demyelination in sensory tracts of the spinal cord or brainstem [5].
Key features that suggest MS rather than other causes:
- Symptoms persist for more than 48 hours (unlike positional nerve compression, which resolves quickly)
- Distribution does not follow a single nerve or dermatome (unlike carpal tunnel or a pinched nerve)
- Numbness involves an entire limb, one side of the body, or a band-like pattern around the trunk
- Worsens with heat (Uhthoff phenomenon)
A common early pattern is numbness starting in the feet and ascending up one or both legs over several days, sometimes with a tight band-like sensation around the waist or chest. This suggests a spinal cord lesion (transverse myelitis).
Some people describe the band around the chest as a squeezing pressure, sometimes called the “MS hug.” It comes from irritated nerves supplying the muscles between the ribs. Chest tightness has many causes, including heart problems, so new chest pressure still needs prompt medical assessment.
Lhermitte’s Sign
Lhermitte’s sign is an electric shock or buzzing sensation that shoots down the spine or into the limbs when you bend your neck forward. This sign results from demyelination in the cervical spinal cord (posterior columns) and is present in 33-40% of MS patients at some point during the disease [6].
Lhermitte’s sign is not exclusive to MS (cervical spondylosis and B12 deficiency can cause it), but in a young adult without spinal disease, it is a strong indicator that warrants MRI evaluation.
Fatigue
MS fatigue is not normal tiredness. It is a distinct, overwhelming exhaustion that occurs disproportionate to activity level and does not resolve with rest. Approximately 75-95% of MS patients report fatigue, and it is the presenting complaint in about 20% [7].
MS fatigue has two components:
- Primary fatigue: Caused by the disease process itself (central nervous system inflammation, demyelination affecting neural circuits involved in arousal and energy regulation)
- Secondary fatigue: From sleep disruption, depression, pain, medication side effects, and deconditioning
Fatigue alone is too nonspecific to raise MS suspicion, but when combined with other symptoms on this list, it becomes part of a concerning pattern. Our guide to managing MS fatigue covers how neurologists and rehabilitation teams assess and treat it.
Motor Symptoms
Weakness, clumsiness, or a heavy feeling in one limb can signal MS-related demyelination of motor tracts. Early motor symptoms are often subtle:
- Tripping or dragging one foot (foot drop from peroneal nerve pathway involvement)
- Difficulty with fine motor tasks (buttoning shirts, writing)
- A feeling that one leg “gives out” during walking or climbing stairs
- Muscle stiffness or spasticity, particularly in the legs
Motor symptoms tend to be more persistent than sensory symptoms and often prompt medical attention sooner.
Less Common but Important Early Signs
Balance and Coordination Problems
Cerebellar or brainstem lesions can cause unsteadiness, vertigo, or difficulty with coordination. Patients may feel drunk or off-balance despite clear proprioception. Intention tremor (tremor that worsens when reaching for objects) suggests cerebellar involvement.
Double Vision and Eye Movement Problems
Double vision (diplopia) that appears when looking to one side can be an early sign of a brainstem lesion. A typical MS finding is internuclear ophthalmoplegia, in which one eye fails to turn inward fully while the other eye flickers. Double vision in a young adult deserves a neurological exam, and sudden double vision with facial droop or slurred speech needs emergency care because it can signal a stroke.
Bladder Dysfunction
Urinary urgency, frequency, or hesitancy affects 80% of MS patients over the disease course and can be an early symptom. Young adults developing overactive bladder symptoms without clear urological cause should consider MS screening, especially if other neurological symptoms are present.
Cognitive Changes
Slowed processing speed, difficulty with multitasking, and “brain fog” can appear early in MS. These cognitive changes are often dismissed as stress or anxiety. Formal neuropsychological testing can detect subtle deficits that bedside assessment misses.
Brain fog has many causes, from poor sleep and thyroid disease to long COVID and menopause, and our overview of common causes of brain fog walks through them. In MS, cognitive change usually shows up alongside physical signs rather than on its own.
Heat Sensitivity (Uhthoff Phenomenon)
Neurological symptoms that worsen with heat exposure (hot showers, exercise, warm weather) are characteristic of MS. In demyelinated nerve fibers, conduction slows or fails at elevated temperatures. This was historically used as a diagnostic test (the “hot bath test”) before MRI became available [8].
If your symptoms consistently worsen with heat and improve with cooling, mention this pattern to your doctor.
Signs in the Years Before Diagnosis (the MS Prodrome)
Researchers now describe an MS prodrome: a period of vague, nonspecific health problems before the first clear neurological attack. A study in The Lancet Neurology by Wijnands and colleagues (2017) found that people later diagnosed with MS saw doctors and used hospitals more often in the 5 years before their first demyelinating event than people without MS [12].
The prodrome tends to involve fatigue, sleep problems, pain, headaches, and mood changes such as anxiety and depression. These findings come from population data and cannot be used to diagnose an individual. They do explain why many people with MS look back and recognize symptoms that started well before diagnosis.
Red Flags: When to Push for Evaluation
Individual symptoms on this list are common and usually benign. The following combinations or characteristics should prompt evaluation:
- Neurological symptoms in a person aged 20-50 (MS peak onset)
- Symptoms that come and go in episodes lasting days to weeks (relapsing-remitting pattern)
- Two or more types of neurological symptoms (e.g., numbness plus vision changes, or fatigue plus balance problems)
- Symptoms that are worse with heat
- Family history of MS or other autoimmune diseases
- Lhermitte’s sign
If your primary care doctor is not taking your symptoms seriously, request a referral to a neurologist directly. Be specific about the pattern: “I’ve had numbness in my right leg for three weeks that worsens when I take hot showers, and last year I had an episode of blurry vision in one eye.” This framing helps clinicians connect the dots.
Some symptoms need emergency care rather than a referral. Sudden weakness or numbness on one side of the face or body, sudden loss of vision, slurred speech, or a severe sudden headache can signal a stroke, which is treated within hours.
What Else Can Cause Early MS-Like Symptoms?
Many conditions mimic the early signs of MS, which is why neurologists rule them out before making a diagnosis. Common mimics include:
- Vitamin B12 deficiency: causes numbness, tingling, balance problems and sometimes Lhermitte’s sign, and is found with a simple blood test.
- Neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody disease (MOGAD): cause optic neuritis and spinal cord inflammation and are separated from MS with antibody blood tests.
- Lyme disease: can cause nerve symptoms and fatigue in people with tick exposure; read more on our Lyme disease condition page.
- Migraine: aura can produce visual changes and tingling, and migraine can leave small white spots on MRI that are sometimes mistaken for MS lesions; see our migraine overview.
- Lupus, Sjögren’s disease and sarcoidosis: autoimmune and inflammatory diseases that can involve the nervous system.
- Cervical spondylosis, carpal tunnel syndrome and pinched nerves: cause numbness that follows a single nerve or root.
- Anxiety and functional neurological disorder: can produce real tingling, dizziness and weakness without demyelination.
Misdiagnosis runs in both directions. Some people with MS are told their symptoms are stress, and some people without MS are told they have it because of nonspecific MRI spots, so a careful exam by a neurologist matters.
What to Do If You Notice Early Signs of MS
A clear record of your symptoms speeds up evaluation. These steps help a clinician decide whether MRI is needed:
- Write down each symptom, the date it started, how long it lasted, and which body part it affected.
- Note whether heat, exercise or a hot shower makes it worse, and whether it eases when you cool down.
- List past episodes that resolved on their own, such as a spell of blurry vision or a numb leg years ago.
- See your primary care doctor and ask for blood work that rules out B12 deficiency, thyroid disease and other mimics.
- Ask for a referral to a neurologist if symptoms persist beyond 24 to 48 hours or come back in episodes.
- Ask whether an MRI of the brain and spinal cord, with and without gadolinium contrast, is appropriate.
How MS Is Diagnosed
Diagnosis requires demonstrating that demyelinating lesions have occurred in multiple locations in the central nervous system (dissemination in space) at different times (dissemination in time). The 2017 revised McDonald criteria allow diagnosis based on [9]:
- MRI of brain and spinal cord: The primary diagnostic tool. MS lesions appear as bright spots on T2-weighted and FLAIR sequences. Gadolinium-enhancing lesions indicate active inflammation.
- Cerebrospinal fluid analysis: Lumbar puncture can show oligoclonal bands (proteins produced by intrathecal immune activation), present in 90-95% of MS patients.
- Visual evoked potentials: Measures the speed of optic nerve conduction. Delayed responses indicate prior optic neuritis, even if subclinical.
- Blood work: Primarily to exclude mimics (vitamin B12 deficiency, Lyme disease, lupus, neuromyelitis optica spectrum disorder, sarcoidosis).
A further revision of the McDonald criteria, presented at the ECTRIMS congress in 2024, adds the optic nerve as a lesion location and allows newer MRI markers such as the central vein sign. No single blood test diagnoses MS. The National Institute of Neurological Disorders and Stroke (NINDS) MS overview describes the same combination of history, exam, MRI and spinal fluid testing.
What a Clinically Isolated Syndrome Means
A clinically isolated syndrome (CIS) is a single episode of neurological symptoms caused by demyelination that has not yet met criteria for MS. If MRI shows additional subclinical lesions at the time of the first episode, about 60-80% of people go on to develop MS over roughly 20 years of follow-up. When the first MRI is normal, the risk is roughly 20% [10].
Starting disease-modifying therapy at the CIS stage (when MRI suggests high risk) significantly reduces the chance of a second clinical attack and delays disability progression.
Who Treats MS After the First Signs?
A neurologist, ideally one who specializes in MS, confirms the diagnosis and prescribes disease-modifying therapy. The FDA has approved many DMTs for relapsing MS, including interferon beta, glatiramer acetate, dimethyl fumarate, fingolimod, natalizumab, ocrelizumab and ofatumumab. Ocrelizumab is also approved for primary progressive MS. Neuro-ophthalmologists, urologists, physical and occupational therapists, and psychologists often join the care team.
Many people also look for supportive care around their neurologist’s plan, such as help with fatigue, diet, rehabilitation and stress. Our guide to multiple sclerosis treatment approaches explains what integrative and regenerative clinics offer and where the evidence is thin. Most of these services are cash pay, several are off label, and none replaces a DMT.
Stem cell therapy for MS is a good example. Autologous hematopoietic stem cell transplantation (aHSCT) is being studied in clinical trials for highly active relapsing MS, while stem cell products sold at private clinics are not FDA approved for MS. Our article on stem cell therapy for MS covers the trial data in more detail.
If you want to compare providers, you can browse clinics offering MS care across the US. Listing order is not paid ranking, and inclusion in the directory is not an endorsement, so check each clinic’s credentials and ask how its services fit with your neurologist’s plan. Our multiple sclerosis condition page links related treatments and resources.
Frequently Asked Questions
What are usually the first signs of MS?
The most common first sign of MS is numbness or tingling in a limb, one side of the body, or a band around the trunk, reported first by about 30-40% of patients. Optic neuritis, with pain on eye movement and blurred vision in one eye, comes first in about 20-25%. Other early signs include unusual fatigue, weakness or clumsiness in a leg, balance problems, double vision, and Lhermitte’s sign, an electric shock down the spine when bending the neck.
Can early MS symptoms come and go?
Yes, early MS symptoms often come and go. Most people start with relapsing-remitting MS, in which attacks develop over hours to days, last days to weeks, and then improve partly or fully. Because symptoms fade, many people dismiss them. A neurological symptom that lasts more than 24 to 48 hours and later returns, in the same or a different part of the body, is a pattern worth reporting to a doctor.
At what age do MS symptoms usually start?
MS symptoms usually start between the ages of 20 and 50, with most people diagnosed in their 20s, 30s or 40s. Women are diagnosed much more often than men. MS can begin in childhood or after 50, though less often, and late-onset MS more often starts with gradually worsening walking problems than with sudden attacks such as optic neuritis.
Can a blood test detect MS?
No blood test can detect or rule out MS on its own. Neurologists diagnose MS with the McDonald criteria, which rely on symptoms, a neurological exam, and MRI of the brain and spinal cord, often with a lumbar puncture to look for oligoclonal bands. Blood tests are still important because they exclude conditions that look like MS, such as vitamin B12 deficiency, Lyme disease, lupus, and neuromyelitis optica spectrum disorder.
Are the early signs of MS different in women?
The early signs of MS are largely the same in women and men: numbness, tingling, optic neuritis, fatigue, weakness, and balance problems. Women develop MS much more often than men, so these symptoms are more often MS in women of childbearing age. Women more often start with relapsing-remitting MS, and relapses tend to quiet during pregnancy and rise in the months after delivery, which is worth discussing with a neurologist when planning a family.
What kind of doctor should I see for early signs of MS?
A neurologist is the right doctor for possible early signs of MS, and an MS specialist is ideal once MRI shows lesions. Start with your primary care doctor, who can order blood work and refer you. Sudden painful vision loss in one eye may first be seen by an ophthalmologist or neuro-ophthalmologist. Bring a written timeline of your symptoms, including any past episodes that resolved on their own.
Related Reading
- Multiple Sclerosis: The Evidence-Based Guide (Pillar)
- Multiple Sclerosis Symptoms: Early Signs and Progression
- MS Treatment Options: DMTs, Biologics, and Emerging Therapies
- MS Diet: What the Research Actually Shows
Sources
- Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502-1517. doi:10.1016/S0140-6736(08)61620-7 ↩
- He A, Merkel B, Brown JWL, et al. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study. Lancet Neurol. 2020;19(4):307-316. doi:10.1016/S1474-4422(20)30067-3 ↩
- Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83-99. doi:10.1016/S1474-4422(13)70259-X ↩
- Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008;65(6):727-732. doi:10.1001/archneur.65.6.727 ↩
- Kister I, Bacon TE, Chamot E, et al. Natural history of multiple sclerosis symptoms. Int J MS Care. 2013;15(3):146-158. doi:10.7224/1537-2073.2012-053 ↩
- Al-Araji AH, Oger J. Reappraisal of Lhermitte’s sign in multiple sclerosis. Mult Scler. 2005;11(4):398-402. doi:10.1191/1352458505ms1177oa ↩
- Krupp LB, Serafin DJ, Christodoulou C. Multiple sclerosis-associated fatigue. Expert Rev Neurother. 2010;10(9):1437-1447. doi:10.1586/ern.10.99 ↩
- Davis SL, Wilson TE, White AT, Frohman EM. Thermoregulation in multiple sclerosis. J Appl Physiol. 2010;109(5):1531-1537. doi:10.1152/japplphysiol.00460.2010 ↩
- Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. doi:10.1016/S1474-4422(17)30470-2 ↩
- Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol. 2012;11(2):157-169. doi:10.1016/S1474-4422(11)70274-5 ↩
- Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029-e1040. ↩
- Wijnands JMA, Kingwell E, Zhu F, et al. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study. Lancet Neurol. 2017;16(6):445-451. ↩